Your browser doesn't support javascript.
loading
OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists.
Schäfer, Anima M; Meyer Zu Schwabedissen, Henriette E; Bien-Möller, Sandra; Hubeny, Andrea; Vogelgesang, Silke; Oswald, Stefan; Grube, Markus.
Affiliation
  • Schäfer AM; Biopharmacy, Department Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
  • Meyer Zu Schwabedissen HE; Biopharmacy, Department Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
  • Bien-Möller S; Center of Drug Absorption and Transport (C_DAT), Department of Pharmacology and Clinical Pharmacology, University Medicine Greifswald, 17487 Greifswald, Germany.
  • Hubeny A; Center of Drug Absorption and Transport (C_DAT), Department of Pharmacology and Clinical Pharmacology, University Medicine Greifswald, 17487 Greifswald, Germany.
  • Vogelgesang S; Department of Pathology, University Medicine Greifswald, 17487 Greifswald, Germany.
  • Oswald S; Center of Drug Absorption and Transport (C_DAT), Department of Pharmacology and Clinical Pharmacology, University Medicine Greifswald, 17487 Greifswald, Germany.
  • Grube M; Institute of Pharmacology and Toxicology, Rostock, University Medical Center, 18057 Rostock, Germany.
Mol Pharm ; 17(6): 1987-1995, 2020 06 01.
Article in En | MEDLINE | ID: mdl-32343897

Full text: 1 Database: MEDLINE Main subject: Dopamine Antagonists / Dopamine Agonists / Organic Anion Transporters Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2020 Type: Article Affiliation country: Switzerland

Full text: 1 Database: MEDLINE Main subject: Dopamine Antagonists / Dopamine Agonists / Organic Anion Transporters Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2020 Type: Article Affiliation country: Switzerland